PFS Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$15.1M	Buy	43,011 +150	+0.3%	+$52.8K	0.25%	106
2023 Q1	$13.8M	Buy	42,861 +357	+0.8%	+$115K	0.24%	109
2022 Q4	$12.3M	Sell	42,504 -1,560	-4%	-$450K	0.23%	100
2022 Q3	$12.8K	Sell	44,064 -6,014	-12%	-$1.74K	0.23%	92
2022 Q2	$14.1M	Sell	50,078 -6,813	-12%	-$1.92M	0.28%	97
2022 Q1	$14.8M	Sell	56,891 -11,892	-17%	-$3.1M	0.28%	95
2021 Q4	$15.1M	Buy	68,783 +744	+1%	+$163K	0.29%	95
2021 Q3	$13.1M	Buy	68,039 +1,521	+2%	+$292K	0.27%	93
2021 Q2	$13.2M	Buy	66,518 +7,789	+13%	+$1.54M	0.3%	94
2021 Q1	$12.6M	Buy	58,729 +23,104	+65%	+$4.96M	0.32%	84
2020 Q4	$8.36M	Buy	35,625 +7,426	+26%	+$1.74M	0.23%	105
2020 Q3	$7.67M	Buy	28,199 +3,561	+14%	+$969K	0.25%	89
2020 Q2	$7.15M	Buy	24,638 +8,998	+58%	+$2.61M	0.26%	85
2020 Q1	$3.72M	Buy	15,640 +3,261	+26%	+$776K	0.16%	101
2019 Q4	$2.71M	Buy	12,379 +1,757	+17%	+$385K	0.1%	125
2019 Q3	$1.8M	Buy	10,622 +3,710	+54%	+$629K	0.08%	124
2019 Q2	$1.23M	Buy	6,912 +4,669	+208%	+$833K	0.06%	122
2019 Q1	$413K	Buy	+2,243	New	+$413K	0.02%	125